Profil
Roland Kolbeck currently works at Aclaris Therapeutics, Inc., as Chief Scientific Officer from 2025.
Dr. Kolbeck also formerly worked at Spirovant Sciences, Inc., as Chief Scientific Officer.
Dr. Kolbeck received his graduate degree from the University of Regensburg.
Postes actifs de Roland Kolbeck
| Sociétés | Poste | Début |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/07/2025 |
Anciens postes connus de Roland Kolbeck
| Sociétés | Poste | Fin |
|---|---|---|
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Directeur Technique/Scientifique/R&D | - |
Formation de Roland Kolbeck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Health Technology |
















